Skip to content

Efficacy of Siddha Medicine Irunelli Karpam and Kanthaga Thailam in Tinea Corporis

An Open Clinical Trial To Explore Therapeutic Efficacy Of Irunelli Karpam (Internal) And Kanthaga Thailam (External) In Tinea Corporis Among Patients Attending OPD At Government Siddha Medical College Hospital Chennai, A Pilot Study - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/05/068133
Enrollment
30
Registered
2024-05-31
Start date
Unknown
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L00-L99- Diseases of the skin and subcutaneous tissue

Interventions

Intervention1: Irunelli Karpam (Internal) and Kanthaga Thailam (External): Irunelli Karpam (Internal): The one part of purified Nellikkai Kanthagam will be grinded intermittently by adding 2 parts of

Sponsors

Government Siddha Medical College, Chennai
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients seeking treatment for tinea corporis Patients who are having classical symptoms of single or multiple scaly annular lesions with slightly raised, erythematous edge with central clearing in body. Patients will be eligible if they had a Lesion Severity Score of atleast 5

Exclusion criteria

Exclusion criteria: Age below 18 years , Pregnant and lactating mothers, Patients allergic to Sulphur , Presence of any other Skin diseases that may affect outcomes of study like Contact Dermatitis, Nummular eczema , Plaque psoriasis

Design outcomes

Primary

MeasureTime frame
To evaluate the efficacy of Siddha Medicine Irunelli Karpam(Internal) and Kanthaga thailam (External) in treating Tinea corporis patients using Lesion severity Score and photographs will be enclosed before and after treatmentTimepoint: 1 month

Secondary

MeasureTime frame
Assess alleviation in clinical signs and symptoms after the treatment and assessing the improvement of the patient from severe to moderate, moderate to mild through Lesion Severity Score which helps to ensure the wellness of the patient.Timepoint: 1 month

Countries

India

Contacts

Public ContactDr Isabell rafeeda

Government Siddha Medical College, Arumbakkam, Chennai

vrafeeda@yahoo.com9444459047

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026